Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Pulmonary Medicine
Published in: BMC Pulmonary Medicine 1/2012

Open Access 01-12-2012 | Research article

Intratracheally administered titanium dioxide or carbon black nanoparticles do not aggravate elastase-induced pulmonary emphysema in rats

Authors: Agnès Roulet, Lucie Armand, Maylis Dagouassat, Françoise Rogerieux, Angélique Simon-Deckers, Esther Belade, Jeanne Tran Van Nhieu, Sophie Lanone, Jean-Claude Pairon, Ghislaine Lacroix, Jorge Boczkowski

Published in: BMC Pulmonary Medicine | Issue 1/2012

Login to get access

Abstract

Background

Titanium dioxide (TiO2) and carbon black (CB) nanoparticles (NPs) have biological effects that could aggravate pulmonary emphysema. The aim of this study was to evaluate whether pulmonary administration of TiO2 or CB NPs in rats could induce and/or aggravate elastase-induced emphysema, and to investigate the underlying molecular mechanisms.

Methods

On day 1, Sprague-Dawley rats were intratracheally instilled with 25 U kg−1 pancreatic porcine elastase or saline. On day 7, they received an intratracheal instillation of TiO2 or CB (at 100 and 500 μg) dispersed in bovine serum albumin or bovine serum albumin alone. Animals were sacrificed at days 8 or 21, and bronchoalveolar lavage (BAL) cellularity, histological analysis of inflammation and emphysema, and lung mRNA expression of heme oxygenase-1 (HO-1), interleukin-1β (IL-1β), macrophage inflammatory protein-2, monocyte chemotactic protein-1, and matrix metalloprotease (MMP)-1, and -12 were measured. In addition, pulmonary MMP-12 expression was also analyzed at the protein level by immunohistochemistry.

Results

TiO2 NPs per se did not modify the parameters investigated, but CB NPs increased perivascular/peribronchial infiltration, and macrophage MMP-12 expression, without inducing emphysema. Elastase administration increased BAL cellularity, histological inflammation, HO-1, IL-1β and macrophage MMP-12 expression and induced emphysema. Exposure to TiO2 NPs did not modify pulmonary responses to elastase, but exposure to CB NPs aggravated elastase-induced histological inflammation without aggravating emphysema.

Conclusions

TiO2 and CB NPs did not aggravate elastase-induced emphysema. However, CB NPs induced histological inflammation and MMP-12 mRNA and protein expression in macrophages.
Appendix
Available only for authorised users
Literature
1.
Yoshida T, Tuder RM: Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev. 2007, 87 (3): 1047-1082. 10.1152/physrev.00048.2006.CrossRefPubMed
2.
Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006, 3 (11): e442-10.1371/journal.pmed.0030442.CrossRefPubMedPubMedCentral
3.
Abboud RT, Vimalanathan S: Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Int J Tuberc Lung Dis. 2008, 12 (4): 361-367.PubMed
4.
Nel A, Xia T, Madler L, Li N: Toxic potential of materials at the nanolevel. Science. 2006, 311 (5761): 622-627. 10.1126/science.1114397.CrossRefPubMed
5.
Boczkowski J, Hoet P: What’s new in nanotoxicology? Implications for public health from a brief review of the 2008 literature. Nanotoxicology. 2011, 4 (1): 1-14.CrossRef
6.
Baan RA: Carcinogenic hazards from inhaled carbon black, titanium dioxide, and talc not containing asbestos or asbestiform fibers: recent evaluations by an IARC Monographs Working Group. Inhal Toxicol. 2007, 19 (Suppl 1): 213-228.CrossRefPubMed
7.
Johnston HJ, Hutchison GR, Christensen FM, Peters S, Hankin S, Aschberger K, Stone V: A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: The contribution of physico-chemical characteristics. Nanotoxicology. 2010, 4: 207-246. 10.3109/17435390903569639.CrossRefPubMed
8.
Warheit DB, Webb TR, Reed KL, Frerichs S, Sayes CM: Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties. Toxicology. 2007, 230 (1): 90-104. 10.1016/j.tox.2006.11.002.CrossRefPubMed
9.
Yazdi AS, Guarda G, Riteau N, Drexler SK, Tardivel A, Couillin I, Tschopp J: Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and IL-1beta. Proc Natl Acad Sci U S A. 2010, 107 (45): 19449-19454. 10.1073/pnas.1008155107.CrossRefPubMedPubMedCentral
10.
Churg A, Stevens B, Wright JL: Comparison of the uptake of fine and ultrafine TiO2 in a tracheal explant system. Am J Physiol. 1998, 274 (1 Pt 1): L81-86.PubMed
11.
Chen HW, Su SF, Chien CT, Lin WH, Yu SL, Chou CC, Chen JJ, Yang PC: Titanium dioxide nanoparticles induce emphysema-like lung injury in mice. Faseb J. 2006, 20 (13): 2393-2395. 10.1096/fj.06-6485fje.CrossRefPubMed
12.
Hext PM: Current perspectives on particulate induced pulmonary tumours. Hum Exp Toxicol. 1994, 13 (10): 700-715. 10.1177/096032719401301009.CrossRefPubMed
13.
Bachoual R, Boczkowski J, Goven D, Amara N, Tabet L, On D, Lecon-Malas V, Aubier M, Lanone S: Biological effects of particles from the paris subway system. Chem Res Toxicol. 2007, 20 (10): 1426-1433. 10.1021/tx700093j.CrossRefPubMed
14.
Fujita K, Horie M, Kato H, Endoh S, Suzuki M, Nakamura A, Miyauchi A, Yamamoto K, Kinugasa S, Nishio K, et al: Effects of ultrafine TiO2 particles on gene expression profile in human keratinocytes without illumination: involvement of extracellular matrix and cell adhesion. Toxicol Lett. 2009, 191 (2–3): 109-117.CrossRefPubMed
15.
Raymond L, Eck S, Mollmark J, Hays E, Tomek I, Kantor S, Elliott S, Vincenti M: Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta. J Cell Physiol. 2006, 207 (3): 683-688. 10.1002/jcp.20608.CrossRefPubMed
16.
Hussain S, Thomassen LC, Ferecatu I, Borot MC, Andreau K, Martens JA, Fleury J, Baeza-Squiban A, Marano F, Boland S: Carbon black and titanium dioxide nanoparticles elicit distinct apoptotic pathways in bronchial epithelial cells. Part Fibre Toxicol. 2010, 7: 10-10.1186/1743-8977-7-10.CrossRefPubMedPubMedCentral
17.
Val S, Hussain S, Boland S, Hamel R, Baeza-Squiban A, Marano F: Carbon black and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial cells: need for multiparametric evaluation due to adsorption artifacts. Inhal Toxicol. 2009, 21 (Suppl 1): 115-122.CrossRefPubMed
18.
Inoue K, Yanagisawa R, Koike E, Nakamura R, Ichinose T, Tasaka S, Kiyono M, Takano H: Effects of carbon black nanoparticles on elastase-induced emphysematous lung injury in mice. Basic Clin Pharmacol Toxicol. 2011, 108 (4): 234-240. 10.1111/j.1742-7843.2010.00638.x.CrossRefPubMed
19.
Mercer RR, Crapo JD: Structural changes in elastic fibers after pancreatic elastase administration in hamsters. J Appl Physiol. 1992, 72 (4): 1473-1479. 10.1063/1.351711.CrossRefPubMed
20.
Sawada M, Ohno Y, La BL, Funaguchi N, Asai T, Yuhgetsu H, Takemura G, Minatoguchi S, Fujiwara H, Fujiwara T: The Fas/Fas-ligand pathway does not mediate the apoptosis in elastase-induced emphysema in mice. Exp Lung Res. 2007, 33 (6): 277-288. 10.1080/01902140701509458.CrossRefPubMed
21.
Tasaka S, Inoue K, Miyamoto K, Nakano Y, Kamata H, Shinoda H, Hasegawa N, Miyasho T, Satoh M, Takano H, et al: Role of interleukin-6 in elastase-induced lung inflammatory changes in mice. Exp Lung Res. 2010, 36 (6): 362-372. 10.3109/01902141003678590.CrossRefPubMed
22.
Fubini B, Ghiazza M, Fenoglio I: Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology. 2010, 4: 347-363. 10.3109/17435390.2010.509519.CrossRefPubMed
23.
Elgrabli D, Abella-Gallart S, Aguerre-Chariol O, Robidel F, Rogerieux F, Boczkowski J, Lacroix G: Effect of BSA on carbon nanotube dispersion for in vivo and in vitro studies. Nanotoxicology. 2007, 1: 266-278. 10.1080/17435390701775136.CrossRef
24.
Boyer L, Plantier L, Dagouassat M, Lanone S, Goven D, Caramelle P, Berrehar F, Kerbrat S, Dinh-Xuan AT, Crestani B, et al: Role of nitric oxide synthases in elastase-induced emphysema. Lab Invest. 2011, 91 (3): 353-362. 10.1038/labinvest.2010.169.CrossRefPubMed
25.
Elekes K, Helyes Z, Kereskai L, Sandor K, Pinter E, Pozsgai G, Tekus V, Banvolgyi A, Nemeth J, Szuts T, et al: Inhibitory effects of synthetic somatostatin receptor subtype 4 agonists on acute and chronic airway inflammation and hyperreactivity in the mouse. Eur J Pharmacol. 2008, 578 (2–3): 313-322.CrossRefPubMed
26.
Plantier L, Marchand-Adam S, Antico VG, Boyer L, De Coster C, Marchal J, Bachoual R, Mailleux A, Boczkowski J, Crestani B: Keratinocyte growth factor protects against elastase-induced pulmonary emphysema in mice. Am J Physiol Lung Cell Mol Physiol. 2007, 293 (5): L1230-1239. 10.1152/ajplung.00460.2006.CrossRefPubMed
27.
Knudsen L, Weibel ER, Gundersen HJ, Weinstein FV, Ochs M: Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach. J Appl Physiol. 2010, 108 (2): 412-421. 10.1152/japplphysiol.01100.2009.CrossRefPubMed
28.
Hsia CC, Hyde DM, Ochs M, Weibel ER: How to measure lung structure–what for? On the “Standards for the quantitative assessment of lung structure”. Respir Physiol Neurobiol. 2010, 171 (2): 72-74. 10.1016/j.resp.2010.02.016.CrossRefPubMed
29.
Abramoff M, Magelhaes P, Ram S: Image Processing with ImageJ. Biophotonics International. 2004, 11: 36-42.
30.
Mehnert W, Mader K: Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001, 47 (2–3): 165-196.CrossRefPubMed
31.
Oberdorster G, Ferin J, Lehnert BE: Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect. 1994, 102 (Suppl 5): 173-179. 10.1289/ehp.94102s5173.CrossRefPubMedPubMedCentral
32.
Yokohira M, Kuno T, Yamakawa K, Hosokawa K, Matsuda Y, Hashimoto N, Suzuki S, Saoo K, Imaida K: Lung toxicity of 16 fine particles on intratracheal instillation in a bioassay model using f344 male rats. Toxicol Pathol. 2008, 36 (4): 620-631. 10.1177/0192623308318214.CrossRefPubMed
33.
Sager TM, Castranova V: Surface area of particle administered versus mass in determining the pulmonary toxicity of ultrafine and fine carbon black: comparison to ultrafine titanium dioxide. Part Fibre Toxicol. 2009, 6: 15-10.1186/1743-8977-6-15.CrossRefPubMedPubMedCentral
34.
van Dijk WD, Gopal S, Scheepers PT: Nanoparticles in cigarette smoke; real-time undiluted measurements by a scanning mobility particle sizer. Anal Bioanal Chem. 2011, 399 (10): 3573-3578. 10.1007/s00216-011-4701-4.CrossRefPubMedPubMedCentral
35.
Ishii Y, Itoh K, Morishima Y, Kimura T, Kiwamoto T, Iizuka T, Hegab AE, Hosoya T, Nomura A, Sakamoto T, et al: Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J Immunol. 2005, 175 (10): 6968-6975.CrossRefPubMed
36.
Wright JL, Cosio M, Churg A: Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2008, 295 (1): L1-15. 10.1152/ajplung.90200.2008.CrossRefPubMedPubMedCentral
37.
Houghton AM, Quintero PA, Perkins DL, Kobayashi DK, Kelley DG, Marconcini LA, Mecham RP, Senior RM, Shapiro SD: Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest. 2006, 116 (3): 753-759. 10.1172/JCI25617.CrossRefPubMedPubMedCentral
38.
Maeno T, Houghton AM, Quintero PA, Grumelli S, Owen CA, Shapiro SD: CD8+ T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. J Immunol. 2007, 178 (12): 8090-8096.CrossRefPubMed
39.
Monteiller C, Tran L, MacNee W, Faux S, Jones A, Miller B, Donaldson K: The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup Environ Med. 2007, 64 (9): 609-615. 10.1136/oem.2005.024802.CrossRefPubMedPubMedCentral
40.
Oberdorster G, Oberdorster E, Oberdorster J: Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005, 113 (7): 823-839. 10.1289/ehp.7339.CrossRefPubMedPubMedCentral
41.
Singh S, Shi T, Duffin R, Albrecht C, van Berlo D, Hohr D, Fubini B, Martra G, Fenoglio I, Borm PJ, et al: Endocytosis, oxidative stress and IL-8 expression in human lung epithelial cells upon treatment with fine and ultrafine TiO2: role of the specific surface area and of surface methylation of the particles. Toxicol Appl Pharmacol. 2007, 222 (2): 141-151. 10.1016/j.taap.2007.05.001.CrossRefPubMed
42.
Stoeger T, Reinhard C, Takenaka S, Schroeppel A, Karg E, Ritter B, Heyder J, Schulz H: Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environ Health Perspect. 2006, 114 (3): 328-333.CrossRefPubMed
43.
Hussain S, Boland S, Baeza-Squiban A, Hamel R, Thomassen LC, Martens JA, Billon-Galland MA, Fleury-Feith J, Moisan F, Pairon JC, et al: Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount. Toxicology. 2009, 260 (1–3): 142-149.CrossRefPubMed
44.
Hussain S, Vanoirbeek JA, Luyts K, De Vooght V, Verbeken E, Thomassen LC, Martens JA, Dinsdale D, Boland S, Marano F, et al: Lung exposure to nanoparticles modulates an asthmatic response in a mouse model. Eur Respir J. 2011, 37 (2): 299-309. 10.1183/09031936.00168509.CrossRefPubMed
45.
Almolki A, Guenegou A, Golda S, Boyer L, Benallaoua M, Amara N, Bachoual R, Martin C, Rannou F, Lanone S, et al: Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans. Am J Pathol. 2008, 173 (4): 981-992. 10.2353/ajpath.2008.070863.CrossRefPubMedPubMedCentral
46.
Guenegou A, Leynaert B, Benessiano J, Pin I, Demoly P, Neukirch F, Boczkowski J, Aubier M: Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), France. J Med Genet. 2006, 43 (8): e43-10.1136/jmg.2005.039743.CrossRefPubMedPubMedCentral
47.
Li JJ, Muralikrishnan S, Ng CT, Yung LY, Bay BH: Nanoparticle-induced pulmonary toxicity. Exp Biol Med (Maywood). 2010, 235 (9): 1025-1033. 10.1258/ebm.2010.010021.CrossRef
48.
Kobayashi N, Naya M, Endoh S, Maru J, Yamamoto K, Nakanishi J: Comparative pulmonary toxicity study of nano-TiO(2) particles of different sizes and agglomerations in rats: different short- and long-term post-instillation results. Toxicology. 2009, 264 (1–2): 110-118.CrossRefPubMed
49.
Cobos-Correa A, Trojanek JB, Diemer S, Mall MA, Schultz C: Membrane-bound FRET probe visualizes MMP12 activity in pulmonary inflammation. Nat Chem Biol. 2009, 5 (9): 628-630.CrossRefPubMed
50.
Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD: Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science. 1997, 277 (5334): 2002-2004. 10.1126/science.277.5334.2002.CrossRefPubMed
51.
Hunninghake GM, Cho MH, Tesfaigzi Y, Soto-Quiros ME, Avila L, Lasky-Su J, Stidley C, Melen E, Soderhall C, Hallberg J, et al: MMP12, lung function, and COPD in high-risk populations. N Engl J Med. 2009, 361 (27): 2599-2608. 10.1056/NEJMoa0904006.CrossRefPubMedPubMedCentral
52.
Lavigne MC, Eppihimer MJ: Cigarette smoke condensate induces MMP-12 gene expression in airway-like epithelia. Biochem Biophys Res Commun. 2005, 330 (1): 194-203. 10.1016/j.bbrc.2005.02.144.CrossRefPubMed
53.
Ishikawa T, Aoshiba K, Yokohori N, Nagai A: Macrophage colony-stimulating factor aggravates rather than regenerates emphysematous lungs in mice. Respiration. 2006, 73 (4): 538-545. 10.1159/000092545.CrossRefPubMed
54.
Inoue S, Nakamura H, Otake K, Saito H, Terashita K, Sato J, Takeda H, Tomoike H: Impaired pulmonary inflammatory responses are a prominent feature of streptococcal pneumonia in mice with experimental emphysema. Am J Respir Crit Care Med. 2003, 167 (5): 764-770. 10.1164/rccm.2105111.CrossRefPubMed
55.
Pang B, Hong W, West-Barnette SL, Kock ND, Swords WE: Diminished ICAM-1 expression and impaired pulmonary clearance of nontypeable Haemophilus influenzae in a mouse model of chronic obstructive pulmonary disease/emphysema. Infect Immun. 2008, 76 (11): 4959-4967. 10.1128/IAI.00664-08.CrossRefPubMedPubMedCentral
Metadata
Title
Intratracheally administered titanium dioxide or carbon black nanoparticles do not aggravate elastase-induced pulmonary emphysema in rats
Authors
Agnès Roulet
Lucie Armand
Maylis Dagouassat
Françoise Rogerieux
Angélique Simon-Deckers
Esther Belade
Jeanne Tran Van Nhieu
Sophie Lanone
Jean-Claude Pairon
Ghislaine Lacroix
Jorge Boczkowski
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2012
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-12-38

Other articles of this Issue 1/2012

BMC Pulmonary Medicine 1/2012 Go to the issue

Research article

Endotoxin as a determinant of asthma and wheeze among rural dwelling children and adolescents: A case–control study

Research article

Singing classes for chronic obstructive pulmonary disease: a randomized controlled trial

Research article

Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells

Research article

Epidemiology of tobacco use and dependence in adults in a poor peri-urban community in Lima, Peru

Case report

Non drowsy obstructive sleep apnea as a potential cause of resistant hypertension: a case report

Research article

Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits